EQ
Price:
$2.81
Market Cap:
$99.82M
Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune checkpoint receptor. Itolizumab is currently in Phase III trials for acute graft-versus-host disease, has completed Phase Ib studies for asthma, and is also undergoing Phase Ib trials for lupus nephritis. In addition to itolizumab, Equillium is advancing EQ101 for the treatment of cutaneous T cell lymphoma...[Read more]
Industry
Biotechnology
IPO Date
2018-10-12
Stock Exchange
NASDAQ
Ticker
EQ
According to Equillium, Inc.’s latest financial reports and current stock price. The company's current ROE is -61.43%. This represents a change of 64.57% compared to the average of -37.33% of the last 4 quarters.
The mean historical ROE of Equillium, Inc. over the last ten years is -50.84%. The current -61.43% ROE has changed 20.83% with respect to the historical average. Over the past ten years (40 quarters), EQ's ROE was at its highest in in the September 2018 quarter at 47.37%. The ROE was at its lowest in in the June 2025 quarter at -113.51%.
Average
-50.84%
Median
-58.61%
Minimum
-195.44%
Maximum
100.43%
Discovering the peaks and valleys of Equillium, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 233.45%
Maximum Annual ROE = 100.43%
Minimum Annual Increase = -120.32%
Minimum Annual ROE = -195.44%
| Year | ROE | Change |
|---|---|---|
| 2025 | -78.32% | 85.06% |
| 2024 | -42.32% | -28.36% |
| 2023 | -59.08% | -69.77% |
| 2022 | -195.44% | 233.45% |
| 2021 | -58.61% | 37.33% |
| 2020 | -42.68% | -30.17% |
| 2019 | -61.12% | 199.53% |
| 2018 | -20.41% | -120.32% |
The current ROE of Equillium, Inc. (EQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-59.91%
5-year avg
-86.75%
10-year avg
-50.84%
Equillium, Inc.’s ROE is greater than Cue Biopharma, Inc. (-98.30%), greater than Coeptis Therapeutics, Inc. (-89.63%), less than NRx Pharmaceuticals, Inc. (107.73%), less than OS Therapies Incorporated (3.21%), greater than Century Therapeutics, Inc. (-53.23%), greater than Telomir Pharmaceuticals, Inc. Common Stock (-201.23%), less than Outlook Therapeutics, Inc. (178.08%), less than Fortress Biotech, Inc. (163.88%), greater than Spruce Biosciences, Inc. (-155.40%), greater than Medicus Pharma Ltd. Common Stock (-4086.31%),
| Company | ROE | Market cap |
|---|---|---|
| -98.30% | $64.46M | |
| -89.63% | $57.63M | |
| 107.73% | $66.38M | |
| 3.21% | $75.71M | |
| -53.23% | $194.78M | |
| -201.23% | $43.32M | |
| 178.08% | $50.19M | |
| 163.88% | $92.02M | |
| -155.40% | $71.19M | |
| -4086.31% | $7.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Equillium, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Equillium, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Equillium, Inc.'s ROE?
How is the ROE calculated for Equillium, Inc. (EQ)?
What is the highest ROE for Equillium, Inc. (EQ)?
What is the 3-year average ROE for Equillium, Inc. (EQ)?
What is the 5-year average ROE for Equillium, Inc. (EQ)?
How does the current ROE for Equillium, Inc. (EQ) compare to its historical average?